Skip to main content
. 2018 Dec 28;8(1):e011343. doi: 10.1161/JAHA.118.011343

Figure 5.

Figure 5

Pathological metabolic changes can be targeted with several available medications. α‐KG, α‐ketoglutarate; CoA, coenzyme A; CPT, carnitine palmitoyltransferase; DCA, dichloroacetate; FA, fatty acid; FATP, fatty acid transport protein; GLS, glutaminase; Glut, glucose transporter; HK, hexokinase; Me, malic enzyme; PDH, pyruvate dehydrogenase; PDK, pyruvate dehydrogenase kinase; PFK, phosphofructokinase; PPAR‐γ, peroxisome proliferator‐activator‐γ; SLC, solute carrier family; YAP, Yes‐associated protein.